The Biosimilar Nocebo Effect? A Systematic Review of Double-Blinded Versus Open-Label Studies

BACKGROUND: Several authors have hypothesized that adverse drug events (ADEs) upon switching from reference biologics to biosimilar products are related to the nocebo effect. However, a thorough and current review of the existing literature has not been conducted. OBJECTIVE: To evaluate if patient a...

Descripción completa

Detalles Bibliográficos
Autores principales: Odinet, Johlee S., Day, Chelsea E., Cruz, Jennifer L., Heindel, Gregory A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398229/
https://www.ncbi.nlm.nih.gov/pubmed/30247100
http://dx.doi.org/10.18553/jmcp.2018.24.10.952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398229/
https://www.ncbi.nlm.nih.gov/pubmed/30247100
http://dx.doi.org/10.18553/jmcp.2018.24.10.952

Ejemplares similares